An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients

Chawanun Charnsil1 Department of Psychiatry, Chiang Mai University, Chiang Mai, ThailandCorrespondence[email protected]

Salinee Vongpanich2 Medical Affairs Department, Janssen-Cilag, Bangkok, Thailand

Pages 1223-1230 | Published online: 20 Aug 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

World Health OrganizationMental health: schizophrenia Available from: http://www.who.int/mental_health/management/schizophrenia/enAccessed June 19, 2013
Google Scholar
American Psychiatric AssociationAmerican Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006Arlington (VA)American Psychiatric Publishing2006
Google Scholar
GreenMFWhat are the functional consequences of neurocognitive deficits in schizophrenia?Am J Psychiatry19961533213308610818
PubMed Web of Science ®Google Scholar
MatzaLSBuchananRPurdonSBrewster-JordanJZhaoYRevickiDAMeasuring changes in functional status among patients with schizophrenia: the link with cognitive impairmentSchizophr Bull20063266667816829550
PubMed Web of Science ®Google Scholar
TollefsonGDCognitive function in schizophrenic patientsJ Clin Psychiatry199657Suppl 113139
Google Scholar
DavidsonMEmsleyRKramerMEfficacy, safety and response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled studySchizophr Res20079311713017466492
PubMed Web of Science ®Google Scholar
KaneJCanasFKramerMTreatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trialSchizophr Res20079014716117092691
PubMed Web of Science ®Google Scholar
KramerMSimpsonGMaciulisVPaliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled studyJ Clin Psychopharmacol20072761417224706
PubMed Web of Science ®Google Scholar
EmsleyRBerwaertsJEerdekensMEfficacy and safety of oral paliperidone extended-release tablets in the treatment of schizophrenia: pooled data from three 52-week open-label studiesInt Clin Psychopharmacol20082334335618854723
PubMed Web of Science ®Google Scholar
NasrallahHMorosiniPGagnonDDReliability, validity and ability to detect change of the Personal and Social Performance Scale in patients with stable schizophreniaPsychiatry Res200816121322418848731
PubMed Web of Science ®Google Scholar
PatrickDLBurnsTMorosiniPReliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophreniaCurr Med Res Opin20092532533819192977
PubMed Web of Science ®Google Scholar
MorosiniPLMaglianoLBrambillaLDevelopment, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioningActa Psychiatr Scand200010132332910782554
PubMed Web of Science ®Google Scholar
BerkMNgFDoddSThe validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical useJ Eval Clin Pract20081497998318462279
PubMed Web of Science ®Google Scholar
CanusoCMYoussefEABossieCATurkozISchreinerASimpsonGMPaliperidone extended-release tablets in schizophrenia patient previously treated with risperidoneInt Clin Psychopharmacol20082320921518545059
PubMed Web of Science ®Google Scholar
MarderSRKramerMFordLEfficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled studyBiol Psychiatry2007621363137017601495
PubMed Web of Science ®Google Scholar
MelzerHYBoboWVNuamabIFEfficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studiesJ Clin Psychiatry20086981782918466043
PubMed Web of Science ®Google Scholar
HuangMWYangTTTenPREffects of paliperidone extended release on the symptoms and functioning of schizophreniaBMC Clin Pharmacol20121211122225965
PubMedGoogle Scholar
SchmaussMJukicVSiracusanoAFlexible dosing with paliperidone ER in the treatment of patients with acutely exacerbated schizophrenia: results from a single-arm, open-label studyCurr Med Res Opin2012813951404
Web of Science ®Google Scholar
ThavichachartNKongsakonRLoWTThe psychopathological characteristics of treatment discontinuation group in 6-month treatment with paliperidone ERInt J Clin Pract20126696997522994331
PubMed Web of Science ®Google Scholar
BirtJManagement of weight gain associated with antipsychoticsAnn Clin Psychiatry200315495712839432
PubMedGoogle Scholar
AllisonDBMentoreJLHeoMAntipsychotic-induced weight gain: a comprehensive research synthesisAm J Psychiatry19991561686169610553730
PubMed Web of Science ®Google Scholar
AllisonDBCaseyDEAntipsychotic-induced weight gain: a review of the literatureJ Clin Psychiatry200162Suppl 72231
PubMed Web of Science ®Google Scholar
AllisonDBFontaineKRHeoMThe distribution of body mass index among individuals with and without schizophreniaJ Clin Psychiatry19996021522010221280
PubMed Web of Science ®Google Scholar
HarringtonCAEnglishCTolerability of paliperidone: a meta-analysis of randomized, controlled trialsInt Clin Psychopharmacol20102533434120706126
PubMed Web of Science ®Google Scholar
Janssen-Cilag Ltd., ThailandSafety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants (PRESENT) Available from: http://clinicaltrials.gov/ct2/show/NCT01387542
Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date